Literature DB >> 24510780

Subarachnoid hemorrhage: a review of experimental studies on the microcirculation and the neurovascular unit.

Michael K Tso1, R Loch Macdonald.   

Abstract

Increasingly, experimental research in subarachnoid hemorrhage (SAH) has investigated early brain injury and the microcirculation. A number of pathophysiological changes occur in the cerebral microvessels after SAH including altered vasoreactivity, vasoconstriction, inflammation, blood-brain barrier impairment, increased microthrombi, and inversion of neurovascular coupling. This focused review looks at the current state of knowledge regarding the changes that occur in the microcirculation and the neurovascular unit after SAH.

Entities:  

Mesh：

Year:  2014        PMID： 24510780     DOI： 10.1007/s12975-014-0323-4

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN： 1868-4483            Impact factor:   6.829


  100 in total

1.  Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan.

Authors:  Jared M Pisapia; Xiangsheng Xu; Jane Kelly; Jamie Yeung; Geneive Carrion; Huaiyu Tong; Sudha Meghan; Omar M El-Falaky; M Sean Grady; Douglas H Smith; Sergei Zaitsev; Vladimir R Muzykantov; Michael F Stiefel; Sherman C Stein
Journal:  Exp Neurol       Date:  2011-11-04       Impact factor: 5.330

2.  Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms.

Authors:  A ECKER; P A RIEMENSCHNEIDER
Journal:  J Neurosurg       Date:  1951-11       Impact factor: 5.115

3.  Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study.

Authors:  Sherman C Stein; Kevin D Browne; Xiao-Han Chen; Douglas H Smith; David I Graham
Journal:  Neurosurgery       Date:  2006-10       Impact factor: 4.654

4.  Histological dissociation between intra- and extraparenchymal portion of perforating small arteries after experimental subarachnoid hemorrhage in dogs.

Authors:  H Ohkuma; S Suzuki
Journal:  Acta Neuropathol       Date:  1999-10       Impact factor: 17.088

5.  Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage.

Authors:  Rachel Meyer; Steven Deem; N David Yanez; Michael Souter; Arthur Lam; Miriam M Treggiari
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

6.  SAH-induced suppression of voltage-gated K(+) (K (V)) channel currents in parenchymal arteriolar myocytes involves activation of the HB-EGF/EGFR pathway.

Authors:  Masayo Koide; George C Wellman
Journal:  Acta Neurochir Suppl       Date:  2013

7.  Luminal platelet aggregates in functional deficits in parenchymal vessels after subarachnoid hemorrhage.

Authors:  Victor Friedrich; Rowena Flores; Artur Muller; Fatima A Sehba
Journal:  Brain Res       Date:  2010-07-21       Impact factor: 3.252

8.  Prevention of vasospasm in penetrating arteries with MAPK inhibitors in dog double-hemorrhage model.

Authors:  A Y Zubkov; R E Tibbs; K Aoki; J H Zhang
Journal:  Surg Neurol       Date:  2000-09

9.  The role of p53 in brain edema after 24 h of experimental subarachnoid hemorrhage in a rat model.

Authors:  Junhao Yan; Chunhua Chen; Qing Hu; Xiaomei Yang; Jiliang Lei; Lei Yang; Ke Wang; Lihua Qin; Hongyun Huang; Changman Zhou
Journal:  Exp Neurol       Date:  2008-07-15       Impact factor: 5.330

Review 10.  Structure and function of P-selectin glycoprotein ligand-1.

Authors:  K L Moore
Journal:  Leuk Lymphoma       Date:  1998-03
View more
  55 in total

1.  The Role of Oxidative Stress in Microvascular Disturbances after Experimental Subarachnoid Hemorrhage.

Authors:  Toshio Fumoto; Masato Naraoka; Takeshi Katagai; Yuchen Li; Norihito Shimamura; Hiroki Ohkuma
Journal:  Transl Stroke Res       Date:  2019-01-09       Impact factor: 6.829

2.  Aneurysmal subarachnoid hemorrhage--status quo and perspective.

Authors:  Nima Etminan
Journal:  Transl Stroke Res       Date:  2015-04-11       Impact factor: 6.829

3.  What is early brain injury?

Authors:  Hidenori Suzuki
Journal:  Transl Stroke Res       Date:  2014-12-16       Impact factor: 6.829

4.  Inflammation: a Good Research Target to Improve Outcomes of Poor-Grade Subarachnoid Hemorrhage.

Authors:  Hidenori Suzuki
Journal:  Transl Stroke Res       Date:  2019-06-18       Impact factor: 6.829

Review 5.  Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage.

Authors:  Darcy Lidington; Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-14       Impact factor: 6.200

6.  Intraventricular Hemorrhage: the Role of Blood Components in Secondary Injury and Hydrocephalus.

Authors:  Thomas Garton; Richard F Keep; D Andrew Wilkinson; Jennifer M Strahle; Ya Hua; Hugh J L Garton; Guohua Xi
Journal:  Transl Stroke Res       Date:  2016-06-30       Impact factor: 6.829

Review 7.  Venous system in acute brain injury: Mechanisms of pathophysiological change and function.

Authors:  Sheng Chen; Yujie Chen; Liang Xu; Nathanael Matei; Jiping Tang; Hua Feng; JohnH Zhang
Journal:  Exp Neurol       Date:  2015-03-14       Impact factor: 5.330

8.  MRI Characterization in the Acute Phase of Experimental Subarachnoid Hemorrhage.

Authors:  Dewei Guo; D Andrew Wilkinson; B Gregory Thompson; Aditya S Pandey; Richard F Keep; Guohua Xi; Ya Hua
Journal:  Transl Stroke Res       Date:  2016-11-28       Impact factor: 6.829

Review 9.  Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets.

Authors:  Richard F Keep; Anuska V Andjelkovic; Jianming Xiang; Svetlana M Stamatovic; David A Antonetti; Ya Hua; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-08       Impact factor: 6.200

10.  Higher Cerebrospinal Fluid pH may Contribute to the Development of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage.

Authors:  Hidenori Suzuki; Masato Shiba; Yoshinari Nakatsuka; Fumi Nakano; Hirofumi Nishikawa
Journal:  Transl Stroke Res       Date:  2016-09-14       Impact factor: 6.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.